The US National Institutes of Health has awarded seven contracts to companies and academic institutions to develop digital health solutions to help fight the COVID-19 pandemic.
Boehringer Ingelheim has signed a $500 million contract with Click Therapeutics to co-develop and market a digital treatment for patients with schizophrenia.
The UK government’s COVID-19 contact-tracing app is to be launched across England and Wales on 24th September, after months of delays while the project had to be completely reworked.
Health systems in lower-income countries could overtake those in richer countries with AI-enabled technologies, according to a report from Novartis Foundation and Microsoft.
A company that has developed a digital treatment for pain and anxiety – Belgium-based Oncomfort – has raised €10 million in first-round financing that will be used to fund international gro
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.